Ondansetron HCL 4 MG tablet 500S
Ended Awarded Last action
- Contract number
- SPE2DR26F9FR0
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $18,603
Award facts
- Contract value 100% obligated
- $18,603.28 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a firm fixed-price delivery order to AmerisourceBergen Drug Corp on December 12, 2025, for the supply of Ondansetron HCL 4 mg tablets (500-count units) with a ceiling value of $18,603.28 and an ultimate completion date of December 15, 2025. This non-set-aside competitive award is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Ondansetron is a widely-used antiemetic medication commonly prescribed to prevent nausea and vomiting, particularly in military medical settings and veteran healthcare systems.
This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999.99 million and extends through December 2026. The primary IDC serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply a broad range of pharmaceutical products, medical supplies, vaccines, and specialty medications to support military healthcare programs worldwide. AmerisourceBergen's consistent award of competitively-awarded, non-set-aside delivery orders demonstrates its established capability to meet federal pharmaceutical procurement requirements and serve critical healthcare needs across the Defense Health Agency and other government healthcare systems.
Quick answers
Who was awarded contract SPE2DR26F9FR0?
SPE2DR26F9FR0 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 12, 2025.
How much is contract SPE2DR26F9FR0 worth?
The government has obligated $18,603 on SPE2DR26F9FR0.
Is contract SPE2DR26F9FR0 an order under another contract?
Yes. SPE2DR26F9FR0 is a delivery order under SPE2DR25D2206, an indefinite delivery contract.
Was contract SPE2DR26F9FR0 competed?
The extent of competition for SPE2DR26F9FR0 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award